Summaryonly a limited number of anti-diabetic drugs are in clinical use for humans, most of which have adverse health effects, but little impact on disease progression, and none of which cures t2DM or clearly prolongs life.the purpose of this review is to examine the underlying molecular, biological, and physiological differences -from gene regulation to whole-animal and population levels -that help explain why rodents do not serve as reliable models for studying human t2DM. this review will also address how researchers may overcome this translational barrier by employing a wide range of human-based investigational methods that will promote human-relevant discoveries while reducing -and eventually replacing -the use of animals in t2DM research.